Full Press Release Details
Immutep Announces Improving Results from Stage I of Phase II TACTI-002 Study.
IMMP
Immutep Announces Improving Results from Stage I of Phase II TACTI-002 Study
Key Takeaway: Immutep Announces Improving Results from Stage I of Phase II TACTI-002 Study